pfizer agreed to combine its off patent drug business upjohn with mylan  a generic drug maker  amid increasing competition and regulatory scrutiny in the generic drug market .  the combined company will sell pfizers viagra and mylans epipen products and is expected to generate  $20b in annual revenue forming a giant global seller of lower priced drugs . 
